• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病对良性前列腺增生患者下尿路症状及功能障碍的影响。

Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia.

作者信息

Boon T A, Van Venrooij G E, Eckhardt M D

机构信息

Department of Urology (G 05.201), University Medical Center, PO Box 85500, 3508 GA Utrecht, The Netherlands.

出版信息

Curr Urol Rep. 2001 Aug;2(4):297-301. doi: 10.1007/s11934-001-0067-z.

DOI:10.1007/s11934-001-0067-z
PMID:12084255
Abstract

This article reviews the recent literature on men with diabetes mellitus (DM) and concomitant lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). Diabetes is reported to be associated with greater BPH symptom severity. Men with non-insulin-dependent diabetes had the highest median annual prostate growth rate compared with those who had other metabolic disease. Urodynamic evaluations in the reviewed studies were absent. Extensive diagnostic evaluations with urodynamics in our outpatient department revealed that patients with LUTS suggestive of BPH and with concomitant DM hardly differed from those without DM.

摘要

本文综述了近期有关患有糖尿病(DM)并伴有提示良性前列腺增生(BPH)的下尿路症状(LUTS)男性患者的文献。据报道,糖尿病与更严重的BPH症状相关。与患有其他代谢疾病的男性相比,非胰岛素依赖型糖尿病男性的前列腺年中位生长率最高。所综述的研究中缺乏尿动力学评估。我们门诊进行的广泛尿动力学诊断评估显示,伴有提示BPH的LUTS且患有DM的患者与未患DM的患者几乎没有差异。

相似文献

1
Effect of diabetes mellitus on lower urinary tract symptoms and dysfunction in patients with benign prostatic hyperplasia.糖尿病对良性前列腺增生患者下尿路症状及功能障碍的影响。
Curr Urol Rep. 2001 Aug;2(4):297-301. doi: 10.1007/s11934-001-0067-z.
2
The associations among eNOS G894T gene polymorphism, erectile dysfunction, and benign prostate hyperplasia-related lower urinary tract symptoms.eNOS G894T 基因多态性与勃起功能障碍及良性前列腺增生相关下尿路症状的关系。
J Sex Med. 2009 Nov;6(11):3158-65. doi: 10.1111/j.1743-6109.2009.01353.x. Epub 2009 Jun 9.
3
Ejaculatory dysfunction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.男性下尿路症状提示良性前列腺增生伴射精功能障碍。
BJU Int. 2009 Oct;104(7):974-83. doi: 10.1111/j.1464-410X.2009.08503.x. Epub 2009 May 7.
4
Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia.良性前列腺增生继发下尿路症状男性的自主神经系统功能亢进。
J Urol. 2005 Oct;174(4 Pt 1):1327-433. doi: 10.1097/01.ju.0000173072.73702.64.
5
Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.他达拉非每日一次治疗男性下尿路症状(LUTS)合并良性前列腺增生(BPH)而无勃起功能障碍。
BJU Int. 2013 Nov;112(7):990-7. doi: 10.1111/bju.12251. Epub 2013 Aug 13.
6
Benign prostatic hyperplasia (BPH) and prostatitis: prevalence of painful ejaculation in men with clinical BPH.良性前列腺增生(BPH)与前列腺炎:临床诊断为BPH的男性中射精疼痛的患病率
BJU Int. 2005 Mar;95(4):571-4. doi: 10.1111/j.1464-410X.2005.05341.x.
7
The use of alpha1-adrenoceptor antagonists in lower urinary tract symptoms: beyond benign prostatic hyperplasia.α1肾上腺素能受体拮抗剂在下尿路症状中的应用:超越良性前列腺增生
Urology. 2003 Sep;62(3 Suppl 1):34-41. doi: 10.1016/s0090-4295(03)00472-2.
8
[Urodynamic studies on benign prostatic hyperplasia combined with diabetes mellitus].[良性前列腺增生合并糖尿病的尿动力学研究]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2010 Jul;35(7):705-10. doi: 10.3969/j.issn.1672-7347.2010.07.010.
9
Association of increased urine brain derived neurotrophic factor with lower urinary tract symptoms in men with benign prostatic hyperplasia.良性前列腺增生男性尿脑源性神经营养因子增加与下尿路症状的关联
J Huazhong Univ Sci Technolog Med Sci. 2017 Aug;37(4):531-535. doi: 10.1007/s11596-017-1768-y. Epub 2017 Aug 8.
10
Patient-reported outcomes in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) treated with intraprostatic OnabotulinumtoxinA: 3-month results of a prospective single-armed cohort study.前列腺内注射肉毒毒素 A 治疗良性前列腺增生所致下尿路症状(LUTS)男性患者的患者报告结局:一项前瞻性单臂队列研究的 3 个月结果。
BJU Int. 2012 Dec;110(11 Pt C):E837-44. doi: 10.1111/j.1464-410X.2012.11288.x. Epub 2012 Jun 19.

引用本文的文献

1
Impact of Diabetes Mellitus on Lower Urinary Tract Symptoms in Benign Prostatic Hyperplasia Patients: A Meta-Analysis.糖尿病对良性前列腺增生症患者下尿路症状的影响:一项荟萃分析。
Front Endocrinol (Lausanne). 2022 Feb 1;12:741748. doi: 10.3389/fendo.2021.741748. eCollection 2021.
2
Fasting blood glucose level and hypertension risk in aging benign prostatic hyperplasia patients.老年良性前列腺增生患者的空腹血糖水平与高血压风险
Aging (Albany NY). 2019 Jul 3;11(13):4438-4445. doi: 10.18632/aging.102061.
3
Comparison of Clinical and Physiological Parameters for Benign Prostatic Hyperplasia in Hypertensive and Normotensive Patients.

本文引用的文献

1
Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia.高胰岛素血症作为良性前列腺增生发展的一个风险因素。
Eur Urol. 2001 Feb;39(2):151-8. doi: 10.1159/000052430.
2
Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia.
J Urol. 2000 Jun;163(6):1725-9.
3
Lack of association between cystopathy and progression of diabetic nephropathy in insulin-dependent diabetes mellitus.
Scand J Urol Nephrol. 1997 Aug;31(4):365-9. doi: 10.3109/00365599709030621.
4
高血压患者与血压正常患者良性前列腺增生的临床和生理参数比较。
Front Physiol. 2018 Sep 24;9:1330. doi: 10.3389/fphys.2018.01330. eCollection 2018.
4
Association between Diabetes Mellitus and Hypertension in Benign Prostatic Hyperplasia Patients.良性前列腺增生患者中糖尿病与高血压的关联
Chin Med J (Engl). 2018 May 5;131(9):1120-1121. doi: 10.4103/0366-6999.230730.
5
The comparison of GLUT-4 and nNOS expression in diabetic and non-diabetic patients with BPH/LUTS.
Int Urol Nephrol. 2015 Jun;47(6):899-904. doi: 10.1007/s11255-015-0964-6. Epub 2015 Apr 3.
6
Hyperglycemia and insulin resistance and the risk of BPH/LUTS: an update of recent literature.高血糖、胰岛素抵抗与良性前列腺增生/下尿路症状风险:近期文献综述
Curr Urol Rep. 2014 Dec;15(12):462. doi: 10.1007/s11934-014-0462-x.
7
Linking pre-diabetes with benign prostate hyperplasia. IGFBP-3: a conductor of benign prostate hyperplasia development orchestra?将前驱糖尿病与良性前列腺增生联系起来。IGFBP-3:良性前列腺增生发展管弦乐队的指挥?
PLoS One. 2013 Dec 19;8(12):e81411. doi: 10.1371/journal.pone.0081411. eCollection 2013.
8
Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan.良性前列腺增生是糖尿病患者膀胱癌的重要危险因素:一项基于人群的使用台湾全民健康保险的队列研究。
BMC Cancer. 2013 Jan 4;13:7. doi: 10.1186/1471-2407-13-7.
9
Roles of urology as assessed by an analysis of inpatients referred to urology.通过对转诊至泌尿外科的住院患者进行分析来评估泌尿外科的作用。
Korean J Urol. 2012 Sep;53(9):619-24. doi: 10.4111/kju.2012.53.9.619. Epub 2012 Sep 19.
10
Diabetes treatment and progression of benign prostatic hyperplasia in community-dwelling black and white men.社区中黑人和白人男性的糖尿病治疗与良性前列腺增生进展。
Urology. 2012 Jan;79(1):102-8. doi: 10.1016/j.urology.2011.08.065. Epub 2011 Nov 23.
Diabetic cystopathy: relationship to autonomic neuropathy detected by sympathetic skin response.糖尿病性膀胱病:与通过交感神经皮肤反应检测到的自主神经病变的关系。
J Urol. 1997 Feb;157(2):580-4. doi: 10.1016/s0022-5347(01)65209-1.
5
Urodynamic evaluation in simultaneous insulin-dependent diabetes mellitus and end stage renal disease.胰岛素依赖型糖尿病合并终末期肾病患者的尿动力学评估
J Urol. 1996 Jun;155(6):2001-4.
6
Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple.使用线性化被动尿道阻力关系(linPURR)和特定疾病的梗阻分级方法分析膀胱出口功能:从复杂到简单。
World J Urol. 1995;13(1):47-58. doi: 10.1007/BF00182666.
7
The Abrams-Griffiths nomogram.艾布拉姆斯-格里菲思列线图。
World J Urol. 1995;13(1):34-9. doi: 10.1007/BF00182664.
8
Cystometric evaluation of bladder dysfunction in elderly diabetic patients.老年糖尿病患者膀胱功能障碍的膀胱测压评估
Arch Intern Med. 1990 Apr;150(4):810-3.
9
The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.美国泌尿外科学会良性前列腺增生症状指数。美国泌尿外科学会测量委员会。
J Urol. 1992 Nov;148(5):1549-57; discussion 1564. doi: 10.1016/s0022-5347(17)36966-5.